Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 6
1965 4
1966 4
1967 2
1968 2
1969 6
1970 4
1971 3
1972 2
1973 5
1974 6
1975 4
1976 6
1977 3
1978 6
1979 5
1980 8
1981 10
1982 16
1983 12
1984 26
1985 27
1986 33
1987 20
1988 32
1989 24
1990 58
1991 50
1992 61
1993 57
1994 66
1995 67
1996 77
1997 98
1998 99
1999 157
2000 183
2001 176
2002 237
2003 292
2004 343
2005 445
2006 516
2007 587
2008 734
2009 740
2010 859
2011 993
2012 1269
2013 1418
2014 1533
2015 1665
2016 1773
2017 1838
2018 2148
2019 2154
2020 2524
2021 2825
2022 3173
2023 3010
2024 3371
2025 2009
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33,870 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM; DeLLphi-304 Investigators. Mountzios G, et al. Among authors: han jy. N Engl J Med. 2025 Jun 2. doi: 10.1056/NEJMoa2502099. Online ahead of print. N Engl J Med. 2025. PMID: 40454646
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials.
Gevaert P, Desrosiers M, Cornet M, Mullol J, De Corso E, Keles Turel N, Maspero J, Fujieda S, Zhang L, Sousa AR, Woods SJ, Davis AM, Schalkwijk S, Edwards D, Ranganathan P, Follows R, Marshall C, Han JK; ANCHOR-1 and ANCHOR-2 trial investigators. Gevaert P, et al. Among authors: han jk. Lancet. 2025 Mar 15;405(10482):911-926. doi: 10.1016/S0140-6736(25)00197-7. Epub 2025 Mar 1. Lancet. 2025. PMID: 40037388 Clinical Trial.
Biorhythm-mimicking growth hormone patch.
Han J, Wu Z, Zhan S, Sheng T, You J, Yu J, Fu J, Zhang Y, Gu Z. Han J, et al. Nat Mater. 2025 Apr 3. doi: 10.1038/s41563-025-02188-9. Online ahead of print. Nat Mater. 2025. PMID: 40181125
Advances in Concept and Imaging of Interstitial Lung Disease.
Yanagawa M, Han J, Wada N, Song JW, Hwang J, Lee HY, Hata A, Franquet T, Chung MP, Tomiyama N, Hatabu H, Lee KS. Yanagawa M, et al. Among authors: han j. Radiology. 2025 May;315(2):e241252. doi: 10.1148/radiol.241252. Radiology. 2025. PMID: 40358445 Review.
Development of an allosteric adhesion GPCR nanobody with therapeutic potential.
Zheng Y, Jiang D, Lu Y, Zhang C, Huang SM, Lin H, Zhang D, Guo S, Han J, Chen J, He Y, Zhang M, Gao Y, Guo Y, Wei R, Xia M, Qin Y, Liu Z, Yang F, Ge S, Yi F, Yu X, Lin H, Xiao P, Sun JP, Feng S. Zheng Y, et al. Among authors: han j. Nat Chem Biol. 2025 May 15. doi: 10.1038/s41589-025-01896-2. Online ahead of print. Nat Chem Biol. 2025. PMID: 40374856
33,870 results
You have reached the last available page of results. Please see the User Guide for more information.